Cases of rare vulvar ulcers have been diagnosed in adolescent girls after receiving a second dose of the Pfizer messenger RNA (mRNA) shot, according to the April edition of the Journal of Pediatric & Adolescent Gynecology. Six cases of adolescent girls ages 12 to 16 developing painful genital ulcers within four days of their second…
Reports of Rare Vulvar Ulcers in Adolescent Girls Following Pfizer COVID-19 Injections
BA.2 Omicron Subvariant Now Causes Nearly 90 Percent of US COVID-19 Cases: CDC
The BA.2 Omicron subvariant of the CCP virus is being pegged as responsible for causing the vast majority of COVID-19 cases in the United States, according to new data from the Centers for Disease Control and Prevention (CDC). The data, for the week ending April 9 and released by the federal health agency on April 12, indicates…
Two COVID-19 Treatments Show Promise in Trials
Two COVID-19 treatments that have not yet been authorized for administration were successful in clinical trials, the companies behind the drugs announced on April 11. A pill developed to attack cancer was successful in curbing deaths among COVID-19 patients in hospitals deemed high risk for Acute Respiratory Distress Syndrome, according to U.S.-based Veru Inc., the maker…
The Dangers of Wireless Radiation and How to Protect Yourself
Silicon Valley is probably the last place you’d expect to hear health warnings related to your cellphone. But that’s where you’ll find Peter Sullivan, a man with a mission to help the public understand how their devices cause real harm.
CRISPR Gene Editing Finds Possible Therapy to Sickle Cell Anaemia
Researchers from the University of New South Wales (UNSW) have found the mechanism behind sickle cell anaemia and beta thalassemia—common genetic anaemia—through CRISPR (DNA editing) techniques, with the discovery promising for future therapies. “We can use this understanding of the mechanism to help us look for new therapeutic approaches–it’s a key piece of the puzzle,”…
Growing Number of States Changing How They Report COVID-19 Hospitalizations
An increasing number of states and municipalities are changing how they report COVID-19 hospitalizations, cases, and other data, signaling a shift in how policymakers healthcare workers view the CCP virus. For example, in New Hampshire, the state reported seven COVID-19 hospitalizations, down from about two dozen reported during the previous week. Officials said the drop…
Medicare Officially Limits Coverage of Alzheimer’s Drug to Those in Clinical Trials
Medicare will only cover a drug for Alzheimer’s disease for patients in clinical trials, President Joe Biden’s administration announced on April 7. The drug, Aduhelm, is made by Biogen. The government said in January that it planned to limit coverage of the drug, which costs $28,000 a year, to trial enrollees. But the announcement was…
FDA Advisers Oppose Repeated COVID-19 Vaccine Boosters
Experts who advise the U.S. Food and Drug Administration (FDA) on April 6 came out in opposition to a strategy of repeated COVID-19 vaccine boosters within a short period of time, during a meeting where FDA officials said they plan on deciding on the future vaccination strategy by June. “I do not believe that booster…
Microplastics Found in Lung Tissue of Living Humans for First Time: Study
Researchers have discovered microplastics deep in the lungs of living humans for the first time. Scientists at Hull York Medical School in England published their findings in the journal Science of the Total Environment, the first such study to show microplastics in the lung tissue of live people. Microplastics are extremely small plastic particles composed of mixtures of polymers and…
COVID-19 Beware: Cheap and Widely Accessible Drug Could Fight Virus
Researchers from the Australian National University (ANU) have discovered that the cheap and widely used drug, heparin, when inhaled can be a uniquely effective prevention and treatment method for COVID-19. Heparin is currently used to prevent blood from clotting and it is typically administered through an injection. However, early results of an ANU clinical study…
US News
RSS Error: A feed could not be found at `https://www.theepochtimes.com/c-us/feed`; the status code is `200` and content-type is `text/html; charset=utf-8`